301075 Stock Overview
Engages in the research and development, production, and sale of chemical pharmaceutical preparations and its raw materials in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 1/6 |
Tibet Duo Rui Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥21.25 |
| 52 Week High | CN¥29.90 |
| 52 Week Low | CN¥12.60 |
| Beta | -0.16 |
| 11 Month Change | 4.58% |
| 3 Month Change | 20.60% |
| 1 Year Change | -27.35% |
| 33 Year Change | -49.39% |
| 5 Year Change | n/a |
| Change since IPO | -52.68% |
Recent News & Updates
Recent updates
What Tibet Duo Rui Pharmaceutical Co., Ltd.'s (SZSE:301075) 41% Share Price Gain Is Not Telling You
Oct 09
Tibet Duo Rui Pharmaceutical's (SZSE:301075) Solid Earnings May Rest On Weak Foundations
May 01Tibet Duo Rui Pharmaceutical Co.,Ltd. (SZSE:301075) Stock Rockets 44% As Investors Are Less Pessimistic Than Expected
Mar 08Shareholder Returns
| 301075 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 6.6% | -1.8% | -2.6% |
| 1Y | -27.4% | -7.0% | 4.2% |
Return vs Industry: 301075 underperformed the CN Pharmaceuticals industry which returned -7% over the past year.
Return vs Market: 301075 underperformed the CN Market which returned 4.2% over the past year.
Price Volatility
| 301075 volatility | |
|---|---|
| 301075 Average Weekly Movement | 9.6% |
| Pharmaceuticals Industry Average Movement | 7.3% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 301075 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 301075's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 395 | Yong Deng | www.duoruiyy.com |
Tibet Duo Rui Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical pharmaceutical preparations and its raw materials in China. It offers fluid therapy, anesthesiology, analgesic, and first-aid medication products.
Tibet Duo Rui Pharmaceutical Co., Ltd. Fundamentals Summary
| 301075 fundamental statistics | |
|---|---|
| Market cap | CN¥1.66b |
| Earnings (TTM) | -CN¥17.54m |
| Revenue (TTM) | CN¥288.56m |
5.8x
P/S Ratio-95.7x
P/E RatioIs 301075 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301075 income statement (TTM) | |
|---|---|
| Revenue | CN¥288.56m |
| Cost of Revenue | CN¥153.20m |
| Gross Profit | CN¥135.36m |
| Other Expenses | CN¥152.90m |
| Earnings | -CN¥17.54m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.22 |
| Gross Margin | 46.91% |
| Net Profit Margin | -6.08% |
| Debt/Equity Ratio | 30.9% |
How did 301075 perform over the long term?
See historical performance and comparison